SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-271265
Filing Date
2022-10-28
Accepted
2022-10-27 19:52:36
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d380980ds3.htm S-3 283373
2 EX-5.1 d380980dex51.htm EX-5.1 25861
3 EX-23.1 d380980dex231.htm EX-23.1 1261
4 EX-FILING FEES d380980dexfilingfees.htm EX-FILING FEES 80166
5 GRAPHIC g380980g1027045602198.jpg GRAPHIC 2357
6 GRAPHIC g380980g1027045602308.jpg GRAPHIC 1638
7 GRAPHIC g380980g48i09.jpg GRAPHIC 44951
  Complete submission text file 0001193125-22-271265.txt   459587
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-268035 | Film No.: 221338723
SIC: 2834 Pharmaceutical Preparations